Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$151.46M
Total Bought:
$46.63M
Total Sold:
$19.53M
Net Transaction:
+$27.10M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
LENZ Therapeutics, Inc.(LENZ)977,245977,2450$25.12M$28.64M18.91%+$3.52M
Eli Lilly and Company(LLY)9,4168,976-440$7.78M$7.00M4.62%-$779.7K
UnitedHealth Group Incorporated(UNH)12,89516,745+3,850$6.75M$5.22M3.45%-$1.53M
Mineralys Therapeutics, Inc.(MLYS)370,513382,415+11,902$5.88M$5.17M3.42%-$709.7K
Contineum Therapeutics, Inc.CL A(CTNM)800,787800,7870$5.59M$3.18M2.10%-$2.41M
Amgen Inc.(AMGN)10,38511,270+885$3.24M$3.15M2.08%-$88.8K
Vertex Pharmaceuticals Incorporated(VRTX)4,7256,945+2,220$2.29M$3.09M2.04%+$801.1K
Johnson & Johnson(JNJ)21,80019,300-2,500$3.62M$2.95M1.95%-$667.2K
Intuitive Surgical, Inc.(ISRG)5,2505,2500$2.60M$2.85M1.88%+$252.7K
AbbVie Inc.(ABBV)14,80014,8000$3.10M$2.75M1.81%-$353.7K
ORIC Pharmaceuticals, Inc.(ORIC)20,000231,485+211,485$111.6K$2.35M1.55%+$2.24M
Boston Scientific Corporation(BSX)24,22621,126-3,100$2.44M$2.27M1.50%-$174.8K
argenx SEADR(ARGX)3,1034,085+982$1.84M$2.25M1.49%+$415.2K
MBX Biosciences, Inc.(MBX)0191,825+191,825$0$2.19M1.45%+$2.19M
Gilead Sciences, Inc.(GILD)32,02019,690-12,330$3.59M$2.18M1.44%-$1.40M
Palvella Therapeutics, Inc.(PVLA)095,615+95,615$0$2.16M1.42%+$2.16M
Replimune Group, Inc.(REPL)0231,650+231,650$0$2.15M1.42%+$2.15M
Arcus Biosciences, Inc.(RCUS)26,870257,270+230,400$210.9K$2.09M1.38%+$1.88M
Danaher Corporation(DHR)10,57510,5750$2.17M$2.09M1.38%-$76.5K
Abbott Labs18,69815,198-3,500$2.48M$2.07M1.36%-$413.2K
Solid Biosciences0421,580+421,580$0$2.05M1.36%+$2.05M
Rapport Therapeutics, Inc.(RAPP)0179,860+179,860$0$2.05M1.35%+$2.05M
Zenas BioPharma, Inc.(ZBIO)0210,625+210,625$0$2.04M1.35%+$2.04M
Ventyx Biosciences0931,620+931,620$0$1.99M1.32%+$1.99M
Tectonic Therapeutic, Inc.(TECX)098,970+98,970$0$1.97M1.30%+$1.97M
Bicara Therapeutics0201,395+201,395$0$1.87M1.24%+$1.87M
Pfizer Inc.(PFE)59,65077,150+17,500$1.51M$1.87M1.23%+$358.6K
BeOne Medicines AGADR(ONC)2,9277,716+4,789$796.6K$1.87M1.23%+$1.07M
Kura Oncology, Inc.(KURA)0323,572+323,572$0$1.87M1.23%+$1.87M
Tourmaline Bio Inc0116,510+116,510$0$1.86M1.23%+$1.86M
Anaptysbio Inc083,900+83,900$0$1.86M1.23%+$1.86M
Instil Bio, Inc.(TIL)086,220+86,220$0$1.80M1.19%+$1.80M
Immatics N.V.SHS(IMTX)0332,270+332,270$0$1.79M1.18%+$1.79M
BioNTech SEADR(BNTX)17,17516,160-1,015$1.56M$1.72M1.14%+$156.6K
Merck & Co., Inc.(MRK)26,90020,900-6,000$2.41M$1.67M1.10%-$748.3K
Thermo Fisher Scientific Inc.(TMO)3,2503,900+650$1.62M$1.58M1.04%-$34.7K
Stryker Corporation(SYK)6,1003,900-2,200$2.27M$1.55M1.02%-$725.5K
Insmed Incorporated(INSM)15,23014,880-350$1.16M$1.50M0.99%+$335.6K
Regeneron Pharmaceuticals, Inc.(REGN)2,7732,7730$1.76M$1.46M0.96%-$302.9K
Summit Therapeutics Inc.(SMMT)69,24065,220-4,020$1.34M$1.39M0.92%+$52.2K
AstraZeneca PLCADR(AZN)18,79018,640-150$1.38M$1.30M0.86%-$78.5K
BioMarin Pharmaceutical Inc.(BMRN)23,53023,5300$1.66M$1.29M0.85%-$369.9K
Edwards Lifescience015,000+15,000$0$1.17M0.77%+$1.17M
DexCom, Inc.(DXCM)15,00013,200-1,800$1.02M$1.15M0.76%+$127.9K
ARS Pharmaceuticals, Inc.(SPRY)100,20565,785-34,420$1.26M$1.15M0.76%-$112.6K
Alnylam Pharmaceuticals, Inc.(ALNY)5,2053,323-1,882$1.41M$1.08M0.72%-$321.9K
Structure TherapeuADR33,69551,369+17,674$583.3K$1.07M0.70%+$482.1K
Vera Therapeutics, Inc.CL A(VERA)28,34841,418+13,070$680.9K$975.8K0.64%+$294.9K
Merus B V015,675+15,675$0$824.5K0.54%+$824.5K
Globus Medical, Inc.CL A(GMED)013,500+13,500$0$796.8K0.53%+$796.8K
ArriVent BioPharma, Inc.(AVBP)10,09035,580+25,490$186.6K$774.6K0.51%+$588.0K
uniQure N.V.SHS(QURE)57,55055,450-2,100$610.0K$773.0K0.51%+$162.9K
Tarsus Pharmaceuticals, Inc.(TARS)17,25018,535+1,285$886.1K$750.9K0.50%-$135.3K
Trevi Therapeutics, Inc.(TRVI)81,800134,150+52,350$514.5K$733.8K0.48%+$219.3K
MoonLake ImmunotherapeuticsCL A(MLTX)15,10815,1080$590.3K$713.1K0.47%+$122.8K
RadNet, Inc.(RDNT)20,00012,500-7,500$994.4K$711.4K0.47%-$283.0K
Legend Biotech CorporationADR(LEGN)35,96519,627-16,338$1.22M$696.6K0.46%-$523.7K
BridgeBio Pharma, Inc.(BBIO)16,08516,0850$556.1K$694.5K0.46%+$138.5K
Boundless Bio, Inc.(BOLD)678,574678,5740$1.02M$685.4K0.45%-$339.3K
Amicus Therapeutics
COM
107,585119,585+12,000$877.9K$685.2K0.45%-$192.7K
Centene Corporation(CNC)012,500+12,500$0$678.5K0.45%+$678.5K
Omada Health, Inc.(OMDA)034,500+34,500$0$631.4K0.42%+$631.4K
Ascendis Pharma A/SADR(ASND)2,0913,471+1,380$325.9K$599.1K0.40%+$273.2K
The Cigna Group(CI)01,800+1,800$0$595.0K0.39%+$595.0K
Syndax Pharmaceuticals, Inc.(SNDX)063,300+63,300$0$592.8K0.39%+$592.8K
Kestra Med TechnologSHS
SHS
035,000+35,000$0$580.3K0.38%+$580.3K
Roivant Sciences Ltd.SHS(ROIV)48,90750,007+1,100$493.5K$563.6K0.37%+$70.1K
Zai Lab LimitedADR(ZLAB)29,92015,840-14,080$1.08M$553.9K0.37%-$527.4K
Bristol-Myers Squibb Company(BMY)19,50010,800-8,700$1.19M$499.9K0.33%-$689.4K
Hinge Health, Inc.CL A(HNGE)09,206+9,206$0$476.4K0.31%+$476.4K
CVRx, Inc.(CVRX)68,50073,500+5,000$837.8K$432.2K0.29%-$405.6K
PTC Therapeutics, Inc.(PTCT)8,3508,535+185$425.5K$416.8K0.28%-$8.7K
Incyte Corporation(INCY)6,1456,060-85$372.1K$412.7K0.27%+$40.6K
Cytokinetics, Incorporated(CYTK)18,06811,723-6,345$726.2K$387.3K0.26%-$338.8K
Neurocrine Biosciences, Inc.(NBIX)2,9052,960+55$321.3K$372.0K0.25%+$50.7K
Scholar Rock Holding Corporation(SRRK)010,380+10,380$0$367.7K0.24%+$367.7K
Ionis Pharmaceuticals, Inc.(IONS)9,4409,205-235$284.8K$363.7K0.24%+$78.9K
Royalty Pharma plcCL A(RPRX)9,2809,2800$288.9K$334.4K0.22%+$45.5K
Biogen Inc.(BIIB)2,8552,375-480$390.7K$298.3K0.20%-$92.4K
Illumina, Inc.(ILMN)3,6822,782-900$292.1K$265.4K0.18%-$26.7K
Jazz Pharmaceuticals plcSHS USD(JAZZ)2,2742,2740$282.3K$241.3K0.16%-$41.0K
Tempus AI, Inc.CL A(TEM)2,1603,760+1,600$104.2K$238.9K0.16%+$134.7K
Revolution Medicines, Inc.(RVMD)6,2406,2400$220.6K$229.6K0.15%+$8.9K
Caris Life Sciences, Inc.(CAI)08,350+8,350$0$223.1K0.15%+$223.1K
Madrigal Pharmaceuticals, Inc.(MDGL)7307300$241.8K$220.9K0.15%-$20.9K
United Therapeutics Corporation(UTHR)7657650$235.8K$219.8K0.15%-$16.0K
Viatris Inc.(VTRS)19,80019,8000$172.5K$176.8K0.12%+$4.4K
Medpace Holdings, Inc.(MEDP)5315310$161.8K$166.7K0.11%+$4.9K
Io Biotech Inc95,000117,691+22,691$103.5K$163.6K0.11%+$60.0K
Moderna, Inc.(MRNA)5,6005,6000$158.8K$154.5K0.10%-$4.3K
Vaxcyte, Inc.(PCVX)21,0404,205-16,835$794.5K$136.7K0.09%-$657.8K
CRISPR Therapeutics AGNAMEN AKT(CRSP)2,5402,5400$86.4K$123.5K0.08%+$37.1K
Axsome Therapeutics, Inc.(AXSM)1,0201,0200$119.0K$106.5K0.07%-$12.5K
Recursion Pharmaceuticals, Inc.CL A(RXRX)11,50011,5000$60.8K$58.2K0.04%-$2.6K
Arvinas, Inc.(ARVN)12,9300-12,930$90.8K$0—-$90.8K
Blueprint Medicines Corp11,2350-11,235$994.4K$0—-$994.4K
Clover Health Investments, Corp.CL A(CLOV)183,0000-183,000$657.0K$0—-$657.0K
Cogent Biosciences, Inc.(COGT)79,0200-79,020$473.3K$0—-$473.3K
Crinetics Pharmaceuticals Inc5,7100-5,710$191.5K$0—-$191.5K
Elevance Health, Inc.(ELV)1,5000-1,500$652.4K$0—-$652.4K
Page 1 of 2
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q2 2025 | TickerTrail